- Disease-modifying treatment approaches in Huntington disease: Past and future2022 | 1. lékařská fakulta
- Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS2017 | 1. lékařská fakulta
- Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment2014 | 1. lékařská fakulta
- Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study2019 | 1. lékařská fakulta
- Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry2023 | 1. lékařská fakulta
- Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis2007 | 1. lékařská fakulta
- Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis2007 | Fakulta tělesné výchovy a sportu
- Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers2023 | 1. lékařská fakulta
- The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe2023 | 1. lékařská fakulta
- Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS2019 | Lékařská fakulta v Plzni, 1. lékařská fakulta, Lékařská fakulta v Hradci Králové, Ústřední knihovna, 2. lékařská fakulta, 3. lékařská fakulta
- Tolerability, treatment satisfaction and quality of life outcomes in stable multiple sclerosis patients switched from injectable therapies to auto injected intramuscular interferon beta 1a: The SFERA study2019 | Lékařská fakulta v Hradci Králové
- Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement2021 | 1. lékařská fakulta
- Predictors of treatment switching in the Big Multiple Sclerosis Data Network2023 | 1. lékařská fakulta
- Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine2016 | 1. lékařská fakulta
- Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM2013 | 1. lékařská fakulta
- ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis2018 | 1. lékařská fakulta
- Nové trendy v terapii diabetické neuropatie2012 | Lékařská fakulta v Plzni
- Aktualita z kongresu AAN 2021 : Zabránit migraci lymfocytů může znamenat udržení náskoku před progresí roztroušené sklerózy2021 | 1. lékařská fakulta
- Léčba diabetické neuropatie2012 | Lékařská fakulta v Plzni
- Optimal Alzheimer's disease detection and diagnosis under the sex and gender lens: a crucial step towards precision neurology2021 | 2. lékařská fakulta
- A perspective on multi-target drugs for Alzheimer's disease2020 | Publikace bez příslušnosti k fakultě
- European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy2020 | 2. lékařská fakulta
- How does fingolimod (gilenya(R)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?2013 | 1. lékařská fakulta
- Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients2017 | 1. lékařská fakulta
- Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties2021 | Publikace bez příslušnosti k fakultě
- The direct costs of multiple sclerosis-study in the Czech Republic2018 | Lékařská fakulta v Hradci Králové
- Microsatellite Polymorphism in Haem Oxygenase 1 Gene Promoter in Multiple Sclerosis2012 | 1. lékařská fakulta
- Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management2018 | 1. lékařská fakulta
- Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic2022 | Lékařská fakulta v Plzni, 1. lékařsk á fakulta, Lékařská fakulta v Hradci Králové, 2. lékařská fakulta, 3. lékařská fakulta
- Restrictive cardiomyopathy: definition and diagnosis2022 | 1. lékařská fakulta